Flexible bronchoscopy is a widely used and safe procedure with a reported maximal mortality rate of 0.04% and a major-complications rate of 0.5%. There are, however, only few case descriptions for postinterventional cerebral air embolism and the frequency of this supposedly rare complication is unknown. The current study presents 2 patients with non-small cell lung cancer who suffered fatal cerebral air embolism following diagnostic bronchoscopy with transbronchial needle aspiration and transbronchial biopsy, resulting in a frequency of <0.02% for this severe complication in our institution. In addition to early supportive measures, 1 patient received hyperbaric oxygen therapy as further treatment. Prompt recognition of this complication is mandatory in order to implement appropriate supportive measures. High-flow oxygen should be administered and hyperbaric oxygen therapy may be considered, if available. If possible, positive pressure ventilation should be avoided.

1.
Faguang J, Deguang M, Dongling C, Enqing F, Yonghong X, Tonggang L: Severe complications of bronchoscopy. Respiration 2008;76:429–433.
2.
Pue CA, Pacht ER: Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995;107:430–432.
3.
Simpson FG, Arnold AG, Purvis A, Belfield PW, Muers MF, Cooke NJ: Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax 1986;41:311–317.
4.
Prakash UB, Offord KP, Stubbs SE: Bronchoscopy in North America: the ACCP survey. Chest 1991;100:1668–1675.
5.
Pereira W Jr, Kovnat DM, Snider GL: A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest 1978;73:813–816.
6.
Erickson AD, Irwin RS, Teplitz C, Corrao WM, Tarpey JT: Cerebral air embolism complicating transbronchoscopic lung biopsy. Ann Intern Med 1979;90:937–938.
7.
Strange C, Heffner JE, Collins BS, Brown FM, Sahn SA: Pulmonary hemorrhage and air embolism complicating transbronchial biopsy in pulmonary amyloidosis. Chest 1987;92:367–369.
8.
Feller-Kopman D, Lukanich JM, Shapira G, Kolodny U, Schori B, Edenfield H, Temelkuran B, Ernst A, Schindel Y, Fink Y, Fox J, Bueno R: Gas flow during bronchoscopic ablation therapy causes gas emboli to the heart: a comparative animal study. Chest 2008;133:892–896.
9.
Goldman Y, Panzica PJ, Pinto DS, Delatorre R, Feller-Kopman D, Ernst A: Cardiac arrest due to left ventricular gas embolism after bronchoscopic argon plasma coagulation: a case report. J Bronchol 2007;14:33–35.
10.
Golish JA, Pena CM, Mehta AC: Massive air embolism complicating Nd-YAG laser endobronchial photoresection. Lasers Surg Med 1992;12:338–342.
11.
Reddy C, Majid A, Michaud G, Feller-Kopman D, Eberhardt R, Herth F, Ernst A: Gas embolism following bronchoscopic argon plasma coagulation: a case series. Chest 2008;134:1066–1069.
12.
Blanc P, Boussuges A, Henriette K, Sainty JM, Deleflie M: Iatrogenic cerebral air embolism: importance of an early hyperbaric oxygenation. Intensive Care Med 2002;28:559–563.
13.
van Hulst RA, Drenthen J, Haitsma JJ, Lameris TW, Visser GH, Klein J, Lachmann B: Effects of hyperbaric treatment in cerebral air embolism on intracranial pressure, brain oxygenation, and brain glucose metabolism in the pig. Crit Care Med 2005;33:841–846.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.